AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $509,000 | -32.2% | 180 | 0.0% | 0.00% | – |
| Q1 2022 | $751,000 | -19.6% | 180 | 0.0% | 0.00% | – |
| Q4 2021 | $934,000 | -20.8% | 180 | 0.0% | 0.00% | – |
| Q3 2021 | $1,179,000 | +3.5% | 180 | 0.0% | 0.00% | – |
| Q2 2021 | $1,139,000 | +10.5% | 180 | 0.0% | 0.00% | – |
| Q1 2021 | $1,031,000 | -35.9% | 180 | 0.0% | 0.00% | – |
| Q4 2020 | $1,609,000 | -23.2% | 180 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $2,095,000 | -27.4% | 180 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,885,000 | +167.6% | 180 | 0.0% | 0.00% | – |
| Q1 2020 | $1,078,000 | -52.9% | 180 | 0.0% | 0.00% | – |
| Q4 2019 | $2,289,000 | -94.0% | 180 | -94.2% | 0.00% | -100.0% |
| Q3 2019 | $38,346,000 | -22.8% | 3,088 | 0.0% | 0.01% | -22.2% |
| Q2 2019 | $49,698,000 | – | 3,088 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
| Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
| MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
| SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
| Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
| Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
| Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
| Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
| Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |